110 related articles for article (PubMed ID: 37016468)
1. Targeting FOS attenuates malignant phenotypes of breast cancer: Evidence from in silico and in vitro studies.
Chang D; Li L; Xu Z; Chen X
J Biochem Mol Toxicol; 2023 Jul; 37(7):e23358. PubMed ID: 37016468
[TBL] [Abstract][Full Text] [Related]
2. The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics.
Dong X; Yang Y; Xu G; Tian Z; Yang Q; Gong Y; Wu G
Cancer Med; 2022 Mar; 11(5):1371-1395. PubMed ID: 35037412
[TBL] [Abstract][Full Text] [Related]
3. Expression and potential molecular mechanisms of miR‑204‑5p in breast cancer, based on bioinformatics and a meta‑analysis of 2,306 cases.
Cai KT; Liu AG; Wang ZF; Jiang HW; Zeng JJ; He RQ; Ma J; Chen G; Zhong JC
Mol Med Rep; 2019 Feb; 19(2):1168-1184. PubMed ID: 30569120
[TBL] [Abstract][Full Text] [Related]
4. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.
Xu W; Wang Y; Wang Y; Lv S; Xu X; Dong X
Int J Mol Med; 2019 Aug; 44(2):390-404. PubMed ID: 31198978
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
[TBL] [Abstract][Full Text] [Related]
6. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
7. Identification of Hub Genes to Regulate Breast Cancer Spinal Metastases by Bioinformatics Analyses.
He Y; Cao Y; Wang X; Jisiguleng W; Tao M; Liu J; Wang F; Chao L; Wang W; Li P; Fu H; Xing W; Zhu Z; Huan Y; Yuan H
Comput Math Methods Med; 2021; 2021():5548918. PubMed ID: 34055036
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
[TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
[TBL] [Abstract][Full Text] [Related]
11. Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis.
Hu JW; Ding GY; Fu PY; Tang WG; Sun QM; Zhu XD; Shen YH; Zhou J; Fan J; Sun HC; Huang C
Biomed Res Int; 2020; 2020():6784138. PubMed ID: 32280695
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
13. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
[TBL] [Abstract][Full Text] [Related]
14. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
15. High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer.
Fu H; Li K; Wang S; Li Y
Aging (Albany NY); 2022 Aug; 14(16):6780-6795. PubMed ID: 36040381
[TBL] [Abstract][Full Text] [Related]
16. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
17. The Clinicopathological Significance and Correlative Signaling Pathways of an Autophagy-Related Gene, Ambra1, in Breast Cancer: a Study of 25 Microarray RNA-Seq Datasets and in-House Gene Silencing.
He RQ; Xiong DD; Ma J; Hu XH; Chen G; Sun WL
Cell Physiol Biochem; 2018; 51(3):1027-1040. PubMed ID: 30476925
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
19. Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation.
Yadav DK; Sharma A; Dube P; Shaikh S; Vaghasia H; Rawal RM
Comput Biol Med; 2022 Oct; 149():106036. PubMed ID: 36096037
[TBL] [Abstract][Full Text] [Related]
20. Molecular network-based identification of competing endogenous RNAs in bladder cancer.
Jiang WD; Yuan PC
PLoS One; 2019; 14(8):e0220118. PubMed ID: 31369587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]